Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. - Test2 - elhamkhani - TriplyDB

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.

http://www.wikidata.org/entity/Q33975138

about

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000 Calibration methods used in cancer simulation models and suggested reporting guidelines Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis.Mathematical model of HPV provides insight into impacts of risk factors and vaccine Estimating progression rates for human papillomavirus infection from epidemiological data.Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.Human papillomavirus vaccination in survivors of childhood cancer.The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.Perceptions of and preferences for federally-funded family planning clinics Cost-effectiveness of a potential vaccine for human papillomavirus.Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples.Natural history of anal dysplasia in an HIV-infected clinical care cohort: estimates using multi-state Markov modeling.An updated natural history model of cervical cancer: derivation of model parameters.Updated guidelines for papanicolaou tests, colposcopy, and human papillomavirus testing in adolescents.Anogenital malignancies and pre-malignancies.Efficacy of vaccination against HPV infections to prevent cervical cancer in France: present assessment and pathways to improve vaccination policies Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies.Sexually transmitted diseases treatment guidelines, 2015.Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer.Management strategies and cost effectiveness in the prevention of cervical cancer.Human papillomavirus vaccination: current indications and future directions A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity Evaluating human papillomavirus vaccination programs.Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.Cost-effectiveness of using human papillomavirus 16/18 genotype triage in cervical cancer screening.Cervical cancer in India and HPV vaccination.HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.A modified Latent Class Model assessment of human papillomavirus-based screening tests for cervical lesions in women with atypical glandular cells: a Gynecologic Oncology Group study Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.Extended duration of the detectable stage by adding HPV test in cervical cancer screening The predicted effect of changes in cervical screening practice in the UK: results from a modelling study

P2860

Q21144710-EA36F7B4-091C-42D5-A077-9F43602BE0E0 Q22306086-AD3A3272-22B3-4733-9185-5D3174CA2120 Q28749665-AAC0332D-8721-4B1F-9E13-F78B6F813A73 Q30658080-AD059AF4-509A-43E2-B951-97A0AC4C877F Q30878077-34E28324-FB6D-4E3A-938C-64E4D0F3E10C Q33238047-2D6FF304-A2F7-4A54-A0C6-2DC74D4B988B Q33467330-EA21159A-C202-489B-9770-357E4FB1F966 Q33488325-7C6DEA89-21D2-4B32-90C5-9F6A43DFEF63 Q33523171-FFA8D867-1B90-41A7-8D0E-91E1A7167221 Q33572460-F39E95B6-70F3-455A-83DF-D01961C0DFBB Q33718690-E92FC256-785E-4DA4-80CC-A22424988A57 Q33861438-415DD368-BA1D-4A5B-96B4-DDED8AAEA652 Q33865463-3DF38430-0FEA-4631-8300-59B4530361E9 Q33916649-B28A8A35-5506-4AD2-8BCC-10A2633B9A0B Q33969401-0375E561-BE9B-48F7-A230-FFFB2681306D Q34015521-D62AB3E5-3384-4E00-9B16-8D79E2CA1FDA Q34083083-A82C5692-FA8D-49C4-80E2-1EAF7537C97F Q34121746-73AD7020-AC70-4FAA-BBCD-1778939ACA23 Q34161073-B1A0D84E-FC78-41E6-AD15-4F7D3CC56E34 Q34199773-F3E31F71-9252-4470-BD7A-4AA089668709 Q34251063-D062C6BE-43B8-40F9-B588-3A869956245A Q34479272-6E8A93B7-F440-4428-9EC8-EA452626A82B Q34490267-1C24D50E-B43C-4C7F-B25F-7FAFE61DCB36 Q34625933-BB8B0A19-DCFD-488B-A392-3746398794B9 Q34686752-F40331A7-C0A6-4B16-8347-17B67BD6E5B4 Q35205476-3EBAE01E-3DCD-4C9A-BDCE-E5AA352172E6 Q35558593-773B1ACB-2A27-41CB-9630-6E3EF7B88A32 Q35724932-2566846F-1251-481D-9CB5-F3B1B6F87B23 Q35843279-03E08E86-90D2-43FD-ACFD-C0D8DD20D98E Q35895952-F05C64E2-B74E-4A25-8C65-51B09CA705B6 Q36045104-06D17CBE-5103-47FD-A247-16FD1C1CE4F8 Q36057298-0A770169-EB90-4C6F-A0CC-ADFB2FBB7C6F Q36064395-0EFE138A-95D6-47CD-8CCC-860B7170EC70 Q36071760-7699BFB0-8229-4C8F-9617-69C88CBC6EB2 Q36086827-4C51AC0D-F119-4539-9B66-E4D9F8D44D63 Q36403718-456A13F9-38EC-4BCF-905F-5605A2C2C246 Q36404994-2EE06772-4A64-430E-A2FE-A8A4678B298C Q36534239-B0780A31-8176-411F-8115-904A6E70B226 Q36671682-312DC308-656D-4347-9480-F403E3CA7129 Q36695433-E28419BE-C6FA-4CBC-8C4D-D540F34CF5EC

P2860

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis.

http://www.wikidata.org/entity/Q33975138

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Mathematical model for the nat ...... n and cervical carcinogenesis.

@ast

Mathematical model for the nat ...... n and cervical carcinogenesis.

@en

type

label

Mathematical model for the nat ...... n and cervical carcinogenesis.

@ast

Mathematical model for the nat ...... n and cervical carcinogenesis.

@en

prefLabel

Mathematical model for the nat ...... n and cervical carcinogenesis.

@ast

Mathematical model for the nat ...... n and cervical carcinogenesis.

@en

P1433

Q33975138-2265EE2A-AA42-47FA-8E05-840B9767DA8E

P1476

Q33975138-7A0994AD-2359-456B-B6F8-5B0A6696268E

P2093

Q33975138-23E64329-BEE3-46E2-AED6-B566D1C4E4FB

Q33975138-2AC02866-81A0-4C94-B70C-991D3DB2502C

Q33975138-6514BD26-2568-4D49-842E-6A82206220BB

Q33975138-88117EF3-A7A8-4142-8635-0A0C798D0679

Q33975138-CDEBC60E-DB58-46A0-9A53-4DB05F1E4A44

P304

Q33975138-8671E81A-8528-4258-9455-123E862A32D9

P31

Q33975138-E0D3B13A-6002-44E6-832C-9776639DFCE3

P356

Q33975138-3154F752-4E6C-4CCF-9745-1C4FCE9AF216

P407

Q33975138-EF0D5001-E60F-4D6E-A46D-5AE27702A61C

P433

Q33975138-BC837D4F-1F02-4445-9830-AD9F74C0AE05

P478

Q33975138-99ACBFF4-D35D-4B7B-AB3C-9CB138A0031C

P577

Q33975138-31FD0459-D23A-4743-9FAF-E21616A40603

P5875

Q33975138-AC193F6A-55CB-4290-82EE-6A00A1E88816

P698

Q33975138-04C5E54E-EC9D-4081-92EF-E82E734FB2DB

P356

OXFORDJOURNALS.AJE.A010166

P1433

American Journal of Epidemiology

P1476

Mathematical model for the nat ...... n and cervical carcinogenesis.

@en

P2093

Bastian L

http://www.w3.org/2001/XMLSchema#string

Matchar DB

http://www.w3.org/2001/XMLSchema#string

McCrory DC

http://www.w3.org/2001/XMLSchema#string

Myers ER

http://www.w3.org/2001/XMLSchema#string

Nanda K

http://www.w3.org/2001/XMLSchema#string

P304

1158-1171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OXFORDJOURNALS.AJE.A010166

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12412973

http://www.w3.org/2001/XMLSchema#string

P698

10905528

http://www.w3.org/2001/XMLSchema#string